Metabolomics Analysis of the Mechanism of Yuquan Capsules in the Treatment of T2DM Rats Using UPLC/MS

Mengli Zhang,1,* Zhien Tan,1 Min Ou,1 Taiping Li,1,2 Xiaonan Yang,1 Lu Chen,1 Rui Xiao,3 Na Lu,1 Xijun Wang,2 Fangfang Wu1,3,* 1National Engineering Research Center for Southwest Endangered Medicinal Materials Resources Development, Guangxi Botanical Garden of Medicinal Plants, Nanni...

Full description

Saved in:
Bibliographic Details
Main Authors: Zhang M, Tan Z, Ou M, Li T, Yang X, Chen L, Xiao R, Lu N, Wang X, Wu F
Format: Article
Language:English
Published: Dove Medical Press 2025-03-01
Series:Diabetes, Metabolic Syndrome and Obesity
Subjects:
Online Access:https://www.dovepress.com/metabolomics-analysis-of-the-mechanism-of-yuquan-capsules-in-the-treat-peer-reviewed-fulltext-article-DMSO
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849389272693473280
author Zhang M
Tan Z
Ou M
Li T
Yang X
Chen L
Xiao R
Lu N
Wang X
Wu F
author_facet Zhang M
Tan Z
Ou M
Li T
Yang X
Chen L
Xiao R
Lu N
Wang X
Wu F
author_sort Zhang M
collection DOAJ
description Mengli Zhang,1,* Zhien Tan,1 Min Ou,1 Taiping Li,1,2 Xiaonan Yang,1 Lu Chen,1 Rui Xiao,3 Na Lu,1 Xijun Wang,2 Fangfang Wu1,3,* 1National Engineering Research Center for Southwest Endangered Medicinal Materials Resources Development, Guangxi Botanical Garden of Medicinal Plants, Nanning, People’s Republic of China; 2National Chinmedomics Research Center, National TCM Key Laboratory of Serum Pharmacochemistry, Chinmedomics Research Center of State Administration of TCM, Laboratory of Metabolomics, Department of Pharmaceutical Analysis, Heilongjiang University of Chinese Medicine, Harbin, People’s Republic of China; 3Engineering Research Center of Innovative Traditional Chinese, Zhuang and Yao Materia Medica, Ministry of Education, Guangxi University of Chinese Medicine, Nanning, People’s Republic of China*These authors contributed equally to this workCorrespondence: Fangfang Wu, Email wffttn@163.com Xiaonan Yang, Email nannangood33@163.comPurpose: Yuquan capsule (YQC) is a well-known proprietary Chinese medicine used for the treatment of type 2 diabetes mellitus. The aim of this study was to investigate the potential mechanism and efficacy of YQC in the treatment of T2DM by means of metabolomics.Methods: Thirty-two male SD rats were randomly divided into four groups of control, type 2 diabetic mellitus (T2DM), metformin (Met), and YQC. Establishment of the T2DM model by high-fat diet (HFD) and streptozotocin (STZ). Fasting blood glucose (FBG) and weight were measured weekly, urine output was collected and recorded. The blood, kidney, pancreas, and liver tissue samples were collected at the end of the experiment. Blood samples were analyzed with methods of ELISA, pancreas, and liver tissues were analyzed by pathological sections, and serum was analyzed by metabolomics using ultra-performance liquid chromatography quadrupole time-of-flight coupled with mass spectrometry (UPLC-Q/TOF-MS).Results: It was observed that YQC could reduce blood glucose levels by modulating blood lipid and transaminase indices, and by diminishing the concentration of inflammatory factors within hepatic and pancreatic tissues. Furthermore, YQC restores homeostasis by regulating lipid and amino acid metabolism, engaging 21 biomarkers and 10 metabolic pathways.Conclusion: YQC has the capacity to enhance blood lipid and transaminase levels, suppress the expression of inflammatory factors, and foster the homeostatic progression of metabolic circulation in rats with T2DM.Keywords: type 2 diabetes mellitus, mechanism, lipid metabolism, blood lipid balance
format Article
id doaj-art-af633c0d8b73485ba788a4d550639f73
institution Kabale University
issn 1178-7007
language English
publishDate 2025-03-01
publisher Dove Medical Press
record_format Article
series Diabetes, Metabolic Syndrome and Obesity
spelling doaj-art-af633c0d8b73485ba788a4d550639f732025-08-20T03:42:00ZengDove Medical PressDiabetes, Metabolic Syndrome and Obesity1178-70072025-03-01Volume 18905916101542Metabolomics Analysis of the Mechanism of Yuquan Capsules in the Treatment of T2DM Rats Using UPLC/MSZhang MTan ZOu MLi TYang XChen LXiao RLu NWang XWu FMengli Zhang,1,* Zhien Tan,1 Min Ou,1 Taiping Li,1,2 Xiaonan Yang,1 Lu Chen,1 Rui Xiao,3 Na Lu,1 Xijun Wang,2 Fangfang Wu1,3,* 1National Engineering Research Center for Southwest Endangered Medicinal Materials Resources Development, Guangxi Botanical Garden of Medicinal Plants, Nanning, People’s Republic of China; 2National Chinmedomics Research Center, National TCM Key Laboratory of Serum Pharmacochemistry, Chinmedomics Research Center of State Administration of TCM, Laboratory of Metabolomics, Department of Pharmaceutical Analysis, Heilongjiang University of Chinese Medicine, Harbin, People’s Republic of China; 3Engineering Research Center of Innovative Traditional Chinese, Zhuang and Yao Materia Medica, Ministry of Education, Guangxi University of Chinese Medicine, Nanning, People’s Republic of China*These authors contributed equally to this workCorrespondence: Fangfang Wu, Email wffttn@163.com Xiaonan Yang, Email nannangood33@163.comPurpose: Yuquan capsule (YQC) is a well-known proprietary Chinese medicine used for the treatment of type 2 diabetes mellitus. The aim of this study was to investigate the potential mechanism and efficacy of YQC in the treatment of T2DM by means of metabolomics.Methods: Thirty-two male SD rats were randomly divided into four groups of control, type 2 diabetic mellitus (T2DM), metformin (Met), and YQC. Establishment of the T2DM model by high-fat diet (HFD) and streptozotocin (STZ). Fasting blood glucose (FBG) and weight were measured weekly, urine output was collected and recorded. The blood, kidney, pancreas, and liver tissue samples were collected at the end of the experiment. Blood samples were analyzed with methods of ELISA, pancreas, and liver tissues were analyzed by pathological sections, and serum was analyzed by metabolomics using ultra-performance liquid chromatography quadrupole time-of-flight coupled with mass spectrometry (UPLC-Q/TOF-MS).Results: It was observed that YQC could reduce blood glucose levels by modulating blood lipid and transaminase indices, and by diminishing the concentration of inflammatory factors within hepatic and pancreatic tissues. Furthermore, YQC restores homeostasis by regulating lipid and amino acid metabolism, engaging 21 biomarkers and 10 metabolic pathways.Conclusion: YQC has the capacity to enhance blood lipid and transaminase levels, suppress the expression of inflammatory factors, and foster the homeostatic progression of metabolic circulation in rats with T2DM.Keywords: type 2 diabetes mellitus, mechanism, lipid metabolism, blood lipid balancehttps://www.dovepress.com/metabolomics-analysis-of-the-mechanism-of-yuquan-capsules-in-the-treat-peer-reviewed-fulltext-article-DMSOtype 2 diabetes mellitusmechanismlipid metabolismblood lipid balance
spellingShingle Zhang M
Tan Z
Ou M
Li T
Yang X
Chen L
Xiao R
Lu N
Wang X
Wu F
Metabolomics Analysis of the Mechanism of Yuquan Capsules in the Treatment of T2DM Rats Using UPLC/MS
Diabetes, Metabolic Syndrome and Obesity
type 2 diabetes mellitus
mechanism
lipid metabolism
blood lipid balance
title Metabolomics Analysis of the Mechanism of Yuquan Capsules in the Treatment of T2DM Rats Using UPLC/MS
title_full Metabolomics Analysis of the Mechanism of Yuquan Capsules in the Treatment of T2DM Rats Using UPLC/MS
title_fullStr Metabolomics Analysis of the Mechanism of Yuquan Capsules in the Treatment of T2DM Rats Using UPLC/MS
title_full_unstemmed Metabolomics Analysis of the Mechanism of Yuquan Capsules in the Treatment of T2DM Rats Using UPLC/MS
title_short Metabolomics Analysis of the Mechanism of Yuquan Capsules in the Treatment of T2DM Rats Using UPLC/MS
title_sort metabolomics analysis of the mechanism of yuquan capsules in the treatment of t2dm rats using uplc ms
topic type 2 diabetes mellitus
mechanism
lipid metabolism
blood lipid balance
url https://www.dovepress.com/metabolomics-analysis-of-the-mechanism-of-yuquan-capsules-in-the-treat-peer-reviewed-fulltext-article-DMSO
work_keys_str_mv AT zhangm metabolomicsanalysisofthemechanismofyuquancapsulesinthetreatmentoft2dmratsusinguplcms
AT tanz metabolomicsanalysisofthemechanismofyuquancapsulesinthetreatmentoft2dmratsusinguplcms
AT oum metabolomicsanalysisofthemechanismofyuquancapsulesinthetreatmentoft2dmratsusinguplcms
AT lit metabolomicsanalysisofthemechanismofyuquancapsulesinthetreatmentoft2dmratsusinguplcms
AT yangx metabolomicsanalysisofthemechanismofyuquancapsulesinthetreatmentoft2dmratsusinguplcms
AT chenl metabolomicsanalysisofthemechanismofyuquancapsulesinthetreatmentoft2dmratsusinguplcms
AT xiaor metabolomicsanalysisofthemechanismofyuquancapsulesinthetreatmentoft2dmratsusinguplcms
AT lun metabolomicsanalysisofthemechanismofyuquancapsulesinthetreatmentoft2dmratsusinguplcms
AT wangx metabolomicsanalysisofthemechanismofyuquancapsulesinthetreatmentoft2dmratsusinguplcms
AT wuf metabolomicsanalysisofthemechanismofyuquancapsulesinthetreatmentoft2dmratsusinguplcms